143 related articles for article (PubMed ID: 3929517)
1. Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Barbarino A; De Marinis L; Mancini A; Menini E; D'Amico C; Passeri M; Sambo P; Anile C; Maira G
Acta Endocrinol (Copenh); 1985 Sep; 110(1):10-6. PubMed ID: 3929517
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
[TBL] [Abstract][Full Text] [Related]
3. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Barbarino A; de Marinis L; Menini E; Anile C; Maira G
Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
[TBL] [Abstract][Full Text] [Related]
4. Basal and TRH-stimulated prolactin in patients with pituitary tumours.
Lamberts SW; Birkenhäger JC; Kwa HG
Clin Endocrinol (Oxf); 1976 Nov; 5(6):709-11. PubMed ID: 827399
[TBL] [Abstract][Full Text] [Related]
5. Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
Ghigo E; Ciccarelli E; Bianchi SD; Gatti G; Molinatti GM; Massara F; Müller EE; Camanni F
Acta Endocrinol (Copenh); 1986 May; 112(1):20-7. PubMed ID: 3087130
[TBL] [Abstract][Full Text] [Related]
6. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease.
Barbieri RL; Cooper DS; Daniels GH; Nathan D; Klibanski A; Ridgway EC
Fertil Steril; 1985 Jan; 43(1):66-73. PubMed ID: 3917409
[TBL] [Abstract][Full Text] [Related]
7. Abnormal regulation of prolactin secretion after successful surgery for prolactin-secreting pituitary tumours.
Schlechte JA; Sherman BM
Clin Endocrinol (Oxf); 1981 Aug; 15(2):165-74. PubMed ID: 6796301
[TBL] [Abstract][Full Text] [Related]
8. Serum prolactin in patients with "functionless" chromophobe adenomas before and after therapy.
Samaan NA; Leavens ME; Jesse JH
Acta Endocrinol (Copenh); 1977 Mar; 84(3):449-60. PubMed ID: 402758
[TBL] [Abstract][Full Text] [Related]
9. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Jeske W
Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
11. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
Cabranes JA; Almoguera I; del Olmo J; Prensa A; Pablos I; Charro AL
J Med; 1986; 17(1):25-39. PubMed ID: 3035040
[TBL] [Abstract][Full Text] [Related]
12. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
13. Lack of plasma prolactin response to intravenously injected vasoactive intestinal polypeptide in patients with prolactin-secreting adenoma.
Kaji H; Chihara K; Kita T; Kashio Y; Okimura Y; Fujita T
Acta Endocrinol (Copenh); 1985 Dec; 110(4):445-50. PubMed ID: 4090907
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Moriondo P; Travaglini P; Nissim M; Faglia G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):525-33. PubMed ID: 7226570
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
Arafah BM; Nekl KE; Gold RS; Selman WR
J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
[TBL] [Abstract][Full Text] [Related]
17. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Barbarino A; De Marinis L; Maira G; Menini E; Anile C
J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
[TBL] [Abstract][Full Text] [Related]
18. Effects of naloxone on prolactin-secreting pituitary adenomas.
Shima K; Chigasaki H; Seki K
Neurol Med Chir (Tokyo); 1990 Feb; 30(2):109-12. PubMed ID: 1695330
[TBL] [Abstract][Full Text] [Related]
19. Dynamic testing of prolactin and growth hormone secretion in patients with neuroendocrine disorders.
Müller EE; Cavagnini F; Martinez-Campos A; Maraschini C; Giovannini P; Novelli A; De Leo V
Acta Endocrinol (Copenh); 1984 Oct; 107(2):155-63. PubMed ID: 6437104
[TBL] [Abstract][Full Text] [Related]
20. Comparison of metoclopramide with other dynamic tests of prolactin secretion.
Sowers JR; McCallum RW; Hershman JM; Carlson HE; Sturdevant RA; Meyer N
J Clin Endocrinol Metab; 1976 Sep; 43(3):679-81. PubMed ID: 821965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
